This present study suggests that ERCC1 mediated repair of DNA damage contributes to the clinical outcome in patients with locally advanced inoperable HNSCC treated with cisplatin-based IC and CCRT. The gene discussed is ERCC1; the disease is head and neck squamous cell carcinoma.